Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Eligible for cataract extraction with primary implantation of a posterior chamber IOL
2 to 3+ cataract density
Preoperative ocular pathology that can affect visual acuity
Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.
Previous intraocular or corneal surgery.
Other ocular surgery at the time of the cataract extraction.
Surgical Exclusion Criteria:
Significant intraoperative intraocular bleeding
Detached Descemet’s membrane
Implantation of the intraocular lens in the anterior chamber or sulcus